The FDA has approved Johnson & Johnson’s supplemental new drug application for Caplyta among patients with schizophrenia at ...
New therapies for multiple myeloma are dramatically improving prognosis and extending survival. Better disease control is prolonging remission and allowing patients to live without any sign of disease ...
Every experience leaves a trace in the brain, a memory that can shape future behavior. Alcohol and other addictive substances ...
A predictive model for psoriasis relapse risk demonstrates moderate performance, according to a study published online April ...
Nearly everyone with multiple myeloma relapses. That doesn’t make it easy. A cancer diagnosis is traumatic, especially when the cancer is treatable, but not curable. In multiple myeloma, the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results